Press release
Endometriosis Market Poised to Hit $2.21 Billion by 2029 with Accelerating Growth Trends
Endometriosis Market Size
Endometriosis Market Size Growth Forecast: What to Expect by 2025?
In the recent past, the endometriosis market has seen a swift expansion. It is projected to increase from a $1.4 billion value in 2024 to $1.55 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%. Factors contributing to the growth in this past period include late diagnosis and improved awareness, developments in laparoscopic procedures, hormonal treatments, as well support and advocacy for patients.
How Will the Endometriosis Market Size Evolve and Grow by 2029?
In the coming years, significant expansion is anticipated in the endometriosis market. The market is predicted to reach $2.21 billion by 2029 with a compound annual growth rate (CAGR) of 9.3%. The surge throughout the projection period can be credited to minimally invasive operations, breakthroughs in pharmaceuticals, genetic and epigenetic studies, and the broadening scope of women's healare worldwide. Key trends during the predicted period encompass emphasis on patient-focused care, precision medicine, virtual care with telemedicine, and fertility preservation.
View the full report here:
https://www.thebusinessresearchcompany.com/report/endometriosis-global-market-report
What Drivers Are Propelling the Growth of Endometriosis Market Forward?
The anticipated increase in ovarian cancer cases is believed to drive the future growth of the endometriosis market. The correlation between ovarian cancer, which initiates in the ovaries - the reproductive organs in women that produce eggs and hormones estrogen and progesterone, and endometriosis is well established. Endometriosis often heightens the risk of epithelial ovarian cancer, especially the endometrioid and precise cell cancer subtypes. These are often associated with excessive estrogen levels, further escalating the risk of ovarian cancer. To put it into perspective, in January 2023, the American Cancer Society, a professional US-based organization, predicts an approximate 19,710 newly diagnosed ovarian cancer cases among women in the US that year. The Ovarian Cancer Research Alliance, a US non-profit organization, also reported that 12,810 fatalities occurred due to ovarian cancer in 2022, and this figure rose to 13,270 in 2023. Thus, the rising prevalence of ovarian cancer underpins the growth of the endometriosis market. Endometriosis Market Driver: Amplification of Endometriosis Market Growth through Government Funding
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13035&type=smp
Which Emerging Trends Are Transforming the Endometriosis Market in 2025?
Key players in the endometriosis market are channeling their efforts toward creating innovative drugs like Myfembree to expand treatment options for patients. Newly developed medications for endometriosis are fulfilling a formerly unmet need for effective therapies. For example, in August 2022, Switzerland's Myovant Sciences GmbH and US-based Pfizer Inc. obtained authorisation from the U.S. Food and Drug Administration (FDA) for the use of Myfembree in managing moderate to severe endometriosis-related pain in premenopausal women. Myfembree, comprised of three vital components - relugolix, estradiol, and norethindrone acetate, is a once-a-day medicine delivering evidence-based relief for premenopausal women with dual benefits in one pill. This offers a different treatment pathway for women unable or reluctant to utilise hormone therapy.
What Are the Key Segments in the Endometriosis Market?
The endometriosis market covered in this report is segmented -
1) By Type: Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Other Types
2) By Treatment Type: Hormonal Therapy, Pain Management
3) By Drug: Oral Contraceptives, Progestins, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Gonadotropin Releasing Hormone (GnRH) Analogues, Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs), Other Drugs
4) By End-User: Hospitals, Homecare, Specialty Centers, Other End-Users
Subsegments:
1) By Superficial Peritoneal Lesion: Endometriotic Nodules, Peritoneal Endometriosis
2) By Endometrioma: Chocolate Cysts
3) By Deeply Infiltrating Endometriosis: Bowel Endometriosis, Ureteral Endometriosis, Vaginal Endometriosis
4) By Other Types: Abdominal Endometriosis, Thoracic Endometriosis
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13035&type=smp
Who Are the Key Players Shaping the Endometriosis Market's Competitive Landscape?
Major companies operating in the endometriosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck And Co. Inc., Abbvie Inc., Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Ipsen Pharma Biotech S.A.S., Cadila Pharmaceuticals Ltd., Gedeon Richter PLC, Torrent Pharmaceuticals Ltd., Neurocrine Biosciences Inc., Ferring Pharmaceuticals, Prestige Consumer Healare Inc., Almirall S.A, Evotec BioSystems GmbH, Serum Institute of India Pvt. Ltd., Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., DebioPharm Group, Repros Therapeutics Inc., Meditrina Pharmaceuticals Private Limited, Zenomed Healare Private Limited.
What Geographic Markets Are Powering Growth in the Endometriosis Market?
North America was the largest region in the endometriosis market in 2024. The regions covered in endometriosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13035
"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endometriosis Market Poised to Hit $2.21 Billion by 2029 with Accelerating Growth Trends here
News-ID: 4121982 • Views: …
More Releases from The Business Research Company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for Endometriosis
Endometriosis Treatment Market at $1.55B, 7.7% CAGR
Why Is the Global Endometriosis Treatment Market Expanding So Quickly?
The endometriosis treatment market has grown rapidly in recent years, primarily due to increased awareness, better diagnostic technologies, rising cases of reproductive health disorders, and significant investment in research and drug development. With the market valued at USD 1.55 billion in 2024 and expected to reach USD 3.25 billion by 2034, the global demand for effective treatments continues to accelerate.
Endometriosis affects…
Endometriosis Pain Market Massive Growth opportunity Ahead
Introduction
Endometriosis is a chronic, estrogen-dependent condition in which endometrial-like tissue grows outside the uterus, leading to inflammation, scarring, and adhesions. One of its most debilitating symptoms is pelvic pain, often accompanied by painful periods, infertility, and fatigue. Globally, endometriosis affects an estimated 10% of women of reproductive age, making it a major public health concern.
Despite its prevalence, endometriosis pain has historically been underdiagnosed and undertreated. Patients often face diagnostic delays…
Elevated Ovarian Cancer Incidence Fuels Growth In The Endometriosis Market: A Ke …
The Endometriosis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Endometriosis Market Size and Its Estimated Growth Rate?
In recent years, there has been a swift expansion in the market size of endometriosis. This market is projected to increase from $1.4 billion…
Hope for Rapid, Non-Invasive Endometriosis Diagnosis
New diagnostic test for endometriosis, the ENDOSURE test, offers decision support to clinicians with 99.87% accurate results in less than an hour, could transform women's healthcare
EDMONTON, AB - In a groundbreaking development for women's health featured on Global News Calgary by journalist Jayme Doll on March 12, 2025, the ENDOSURE test emerges as a beacon of hope for millions suffering from undiagnosed endometriosis in. This non-invasive diagnostic tool promises to…
Emerging Endometriosis Market Trend 2025-2034: Innovative Medications Reshaping …
"How Is the Endometriosis Market Projected to Grow, and What Is Its Market Size?
The endometriosis market has seen rapid growth in recent years. It is expected to grow from $1.4 billion in 2024 to $1.55 billion in 2025, at a compound annual growth rate (CAGR) of 10.2%. The growth can be attributed to delayed diagnosis, increased awareness, advances in laparoscopic surgery, hormonal therapies, and the support of patient advocacy groups.
The…
Endometriosis Treatment Market Analysis, Size, Share & Trends | 2031
In recent years, the global Endometriosis Treatment Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Endometriosis Treatment Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five…
